Isidoro C. Barneto - Publications

BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 19, 2024

A new updated prognostic index for patients with brain metastases (BMs) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology. METASNCore project.

Journal: Journal of neuro-oncology

Published: February 04, 2024

Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.

Journal: The New England journal of medicine

Published: June 28, 2023

Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial.

Journal: The Lancet. Respiratory medicine

Published: March 30, 2022

Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer.

Journal: European journal of cancer care

Published: May 02, 2017

Peculiarities of the obese patient with cancer: a national consensus statement by the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 29, 2016

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain.

Journal: BMC cancer

Published: June 20, 2016

Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study.

Journal: Future oncology (London, England)

Published: June 05, 2015

Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 16, 2015

Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 29, 2014